Sotera Health Company
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Alton E. Shader
- Full Time Employees
- 3,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 9100 South Hills Boulevard Broadview Heights OH United States of America 44147
- IPO Date
- Nov 20, 2020
- CIK
- 0001822479
- Website
- soterahealth.com
- Similar Companies
- Business
- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical sterilization solutions, lab testing, and advisory services for the healthcare industry, operates through three primary businesses: Sterigenics, which delivers outsourced terminal sterilization and irradiation services utilizing gamma, ethylene oxide (EtO), electron beam (E-beam), and X-ray modalities for medical devices, pharmaceuticals, food safety, and advanced applications across 48 facilities in 13 countries; Nordion, which supplies reliable Cobalt-60 sources and gamma irradiators essential for the gamma sterilization process; and Nelson Labs, which offers comprehensive microbiological and analytical chemistry testing along with advisory services conducted at 12 global laboratory locations. The company serves approximately 5,000 customers in over 50 countries, including 40 of the top 50 medical device firms and 9 of the top 10 pharmaceutical companies, safeguarding the safety of over 190 million patients and practitioners annually with nearly 200 years of combined expertise across its units headquartered in Broadview Heights, Ohio. In recent developments, Sotera Health completed a $307 million follow-on equity offering in September 2025 by issuing 20 million shares to fund growth initiatives, capacity expansions, and compliance efforts amid rising sterilization demand and regulatory pressures on EtO emissions; announced a secondary offering of 30 million shares in November 2025 by investors Warburg Pincus and GTCR; raised its full-year 2025 revenue guidance reflecting strong end-market growth; and continues investments in high-efficiency sterilization facilities while navigating extended U.S. EPA EtO regulation timelines.
California State Teachers Retirement System Buys 44,092 Shares of Sotera Health Company $SHC
Sotera Health Q2 Earnings Call Highlights
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
Dimensional Fund Advisors LP Buys 358,281 Shares of Sotera Health Company $SHC
Bank of New York Mellon Corp Acquires 166,055 Shares of Sotera Health Company $SHC
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Sotera Health Announces Secondary Offering of Common Stock
Why Broyhill May Be Buying More Sotera Health Shares
Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
Sotera Health Announces Leadership Transition
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates